e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Difficult tuberculosis cases II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Follow up results for tuberculosis in patients who receive TNF antagonist treatment
M. Aydin, T. Cagatay, R. Yildiz, B. Erer, L. Pur, S. Kamali, M. Inanc, A. Gul, Z. Kilicaslan (Istanbul, Turkey)
Source:
Annual Congress 2007 - Difficult tuberculosis cases II
Session:
Difficult tuberculosis cases II
Session type:
Thematic Poster Session
Number:
3842
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Aydin, T. Cagatay, R. Yildiz, B. Erer, L. Pur, S. Kamali, M. Inanc, A. Gul, Z. Kilicaslan (Istanbul, Turkey). Follow up results for tuberculosis in patients who receive TNF antagonist treatment. Eur Respir J 2007; 30: Suppl. 51, 3842
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Follow up results of patients receiving anti tumor necrosis antagonists and evaluation of risk of tuberculosis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Observation results of 484 patients that use TNF alfa inhibitor in respect of the risk of tuberculosis
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008
Effectiveness of official recommendations on tuberculosis screening in patients on TNF antagonists
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
Characteristics of new tuberculosis cases diagnosed during treatment with TNF-alpha antagonists
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
The incidence of tuberculosis in patients taking anti TNF alpha therapy
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
Follow up of newly detected patients with destructive lung tuberculosis who were failed at the end of 8-month chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 648s
Year: 2005
One year follow-up of T-SPOT. TB results in treated patients with active tuberculosis
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy
Source: Eur Respir J 2014; 44: 1369-1372
Year: 2014
Evaluation of follow up and treatment results of new tuberculosis cases
Source: Eur Respir J 2003; 22: Suppl. 45, 522s
Year: 2003
Long-term results of treatment with bedaquiline in patients with drug-resistant tuberculosis
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Follow up of newly detected patients with pulmonary tuberculosis who interrupted treatment and have not treated repeatedly
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006
Treatment and outcome of CRF patients with tuberculosis
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
The results of re-treatment patients with tuberculosis
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008
IP-10 decreases during antituberculous treatment in children with active tuberculosis.
Source: Virtual Congress 2020 – Tuberculosis: part 2
Year: 2020
Our approach about latent tuberculosis infection in patients who are given anti-TNF alpha therapy
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Short 12-month regimen with intravenouse linezolid for MDR-TB: treatment outcomes and first follow up results.
Source: International Congress 2018 – New developments in tuberculosis
Year: 2018
Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004
Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Long-term treatment with infliximab in patients with sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept